Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Avanir Pharmaceuticals Inc. et al v. Sandoz Inc.
Case Number:
1:13-cv-00961
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 14, 2013
Avanir Settles With Sandoz Over Nuedexta Generic Plans
Avanir Pharmaceuticals Inc. has settled a suit in Delaware federal court accusing Sandoz Inc.'s planned generic version of involuntary-emotion treatment Nuedexta of infringing three patents, the company announced Wednesday.
-
May 31, 2013
Avanir Sues Sandoz Over Nuedexta Generic
Avanir Pharmaceuticals Inc. on Thursday sued Sandoz Inc. in Delaware to block its attempt at marketing a generic version of involuntary-emotion drug Nuedexta, claiming Sandoz's copycat drug would infringe its patents.